Details for Patent: 9,585,839

Title:	Particles for use in a pharmaceutical composition
Abstract:	The invention provides a method of making a composition for inhalation which includes the step of mixing particles of additive material having a diameter of not more than 2 .mu.m with active particles, wherein the additive material is suitable for promoting the dispersal of active particles upon aerolization of a dry powder in a dry powder inhaler.
Inventor(s):	Staniforth; John Nicholas (Bath, GB), Morton; David Alexander Vodden (Bath, GB)
Assignee:	VECTURA LIMITED (Chippenham, Wiltshire, GB)
Filing Date:	Oct 10, 2013
Application Number:	14/050,819
Claims:	1. A method of making a composition for inhalation which includes the step of mixing particles of additive material having a diameter of not more than 2 .mu.m with active particles, wherein the additive material is suitable for promoting the dispersal of active particles upon aerolisation of a dry powder in a dry powder inhaler, and the step of pressing the particles of additive material to the surfaces of the active particles by a milling step involving compressing the mixture of active and additive particles in a gap of fixed predetermined width, wherein the additive comprises magnesium stearate. 2. A method as claimed in claim 1 in which the additive particles have a diameter of not more than 1.5 .mu.m. 3. A method as claimed in claim 1 or claim 2, wherein the additive material comprises a further hydrophobic material suitable for delaying the dissolution of an active substance in the lung. 4. A method as claimed in claim 1, in which the additive material further comprises a phospholipid. 5. A method as claimed in claim 1, in which the additive material further comprises an amino acid. 6. A method as claimed in claim 1, in which the additive material is soft. 7. A method as claimed in claim 1 in which the additive particles are in the form of agglomerates. 8. A method as claimed in claim 1 in which the additive particles have a bulk density not more than 0.4 gcm.sup.-3. 9. A method as claimed in claim 1 in which the additive particles are in the form of flakes having a thickness of not more than 0.53 .mu.m. 10. A method as claimed in claim 1 further comprising the step of providing large particles of additive material having a MMAD of greater than 2 .mu.m and the step of reducing the size of those particles such that the MMAD of the resulting particles is less than 2 .mu.m. 11. A method as claimed in claim 10 in which the step of reducing the size of the particles of additive material involves the movement of the particles from a region of high pressure to a region of low pressure. 12. A method as claimed in claim 11 in which the step of reducing the size of the particles of additive material involves homogenisation. 13. A method as claimed in any of claims 10 to 12 further comprising, after the step of reducing the size of the particles of additive material, a spray drying step. 14. A method as claimed in any of claims 10 to 13 in which the particles of active material are also present during the step of reducing the size of the particles of additive material. 15. A composition for inhalation comprising particles of an active substance and additive particles, the composition obtained by a method as claimed in claim 1. 16. A composition as claimed in claim 15 which further comprises carrier particles. 17. A composition as claimed in claim 15 which further comprises a propellant for a pressurised metered dose inhaler. 18. A dry powder inhaler comprising a composition as claimed in claim 14. 19. A pressurised metered dose inhaler which comprises a composition as claimed in claim 15. 20. A composition for inhalation comprising particles of an active substance and magnesium stearate particles embedded into the surface of the active particles, the magnesium stearate particles are in the form of flakes having a thickness of not more than 0.5 .mu.m.